GDF15 and non-small cell lung carcinoma: In locally advanced non-small cell lung cancer (NSCLC) treated with chemoradiotherapy, elevated GDF15 levels correlate with worse recurrence-free survival (RFS) and OS, highlighting its prognostic relevance [84].